<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00983177</url>
  </required_header>
  <id_info>
    <org_study_id>colchicine1</org_study_id>
    <nct_id>NCT00983177</nct_id>
  </id_info>
  <brief_title>Colchicine Treatment for Chronic Shoulder Pain Related to Calcific Tendonitis</brief_title>
  <official_title>Colchicine Treatment for Chronic Shoulder Pain Related to Calcific Tendonitis: Double Blind Placebo-controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bnai Zion Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bnai Zion Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Chronic pain due to calcific tendonitis of shoulder is a prevalent condition usually treated
      with recurrent courses of NSAIDs, physical therapy or surgical interventions. Colchicine has
      been reported to be effective in the acute attack of shoulder tendonitis, however, has never
      been examined in controlled study in patients with chronic shoulder pain secondary to
      calcific tendonitis. Eighty patients with chronic shoulder pain (at least 3 months duration)
      due to calcific tendonitis will be randomized to receive colchicine 0.5 mg twice daily or
      placebo (lactose capsules) for 4 months. At the end of this blinded part of the study,
      patients who received placebo and did not improve, will be eligible to continue study in the
      open mode for additional 4 months with study drug. Efficacy (VAS for shoulder pain, shoulder
      range of motion and shoulder pain and disability index) and safety (blood tests) follow-ups
      will be scheduled bi-monthly for all patients.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2010</start_date>
  <completion_date type="Anticipated">October 2011</completion_date>
  <primary_completion_date type="Anticipated">October 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>VAS for shoulder pain</measure>
    <time_frame>4-8 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>shoulder range of motion</measure>
    <time_frame>4-8 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>shoulder pain and disability index</measure>
    <time_frame>4-8 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Calcific Tendonitis</condition>
  <arm_group>
    <arm_group_label>colchicine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Lactose capsule</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Colchicine</intervention_name>
    <description>0.5 mg twice daily for 4 months</description>
    <arm_group_label>colchicine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>lactose</intervention_name>
    <description>lactose capsules twice daily</description>
    <arm_group_label>Lactose capsule</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  chronic, more than 3 months duration, shoulder pain

          -  tendinous calcifications on shoulder X-rays

        Exclusion Criteria:

          -  renal insufficiency

          -  liver insufficiency

          -  lactose intolerance

          -  hypersensitivity to colchicine
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Itzhak Rosner, MD</last_name>
    <role>Study Director</role>
    <affiliation>Bnai Zion Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gleb Slobodin, MD</last_name>
    <phone>972-506267284</phone>
    <email>gleb.slobodin@b-zion.org.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Bnai Zion Medical Center</name>
      <address>
        <city>Haifa</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gleb Slobodin, MD</last_name>
      <email>gleb.slobodin@b-zion.org.il</email>
    </contact>
    <investigator>
      <last_name>Gleb Slobodin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>July 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 22, 2009</study_first_submitted>
  <study_first_submitted_qc>September 22, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 23, 2009</study_first_posted>
  <last_update_submitted>July 18, 2010</last_update_submitted>
  <last_update_submitted_qc>July 18, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 20, 2010</last_update_posted>
  <responsible_party>
    <name_title>Gleb Slobodin</name_title>
    <organization>Bnai Zion Medical Center</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shoulder Pain</mesh_term>
    <mesh_term>Tendinopathy</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colchicine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

